Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
January 7, 2019
The article discusses how FDNA’s Face2Gene app uses a deep-learning algorithm to identify signs of rare genetic disorders by analyzing facial features. The app leverages advanced AI technology to scan photos, detecting phenotypic markers associated with various genetic conditions. By comparing these features against a vast database, the app provides quick and accurate diagnostic insights. This approach enhances early detection and allows for personalized treatment plans, significantly improving patient outcomes.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…